Stockscreener 앱 받기
3.98
3.65%
0.14
전일 마감가:
$3.84
열려 있는:
$3.74
하루 거래량:
7.80M
Relative Volume:
1.02
시가총액:
$677.72M
수익:
-
순이익/손실:
$-37.34M
주가수익비율:
-2.9265
EPS:
-1.36
순현금흐름:
$-36.91M
1주 성능:
+15.03%
1개월 성능:
+80.91%
6개월 성능:
+107.29%
1년 성능:
+304.97%
1일 변동 폭
$3.6942
$4.10
1주일 범위
$3.34
$4.418
52주 변동 폭
$0.8505
$5.1765
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
명칭
Sellas Life Sciences Group Inc
전화
(646) 200-5278
주소
7 TIMES SQUARE, NEW YORK, NY
SLS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
3.98 | 653.88M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-07-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-01 | 개시 | Oppenheimer | Outperform |
| 2018-04-02 | 개시 | H.C. Wainwright | Buy |
| 2018-03-19 | 업그레이드 | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc 주식(SLS)의 최신 뉴스
Key Developments in SLS’s Market Strategy - StocksToTrade
SELLAS Life Sciences Rallies After Major Trial Developments - timothysykes.com
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration - simplywall.st
Sellas Life Sciences Stock Dips as Volatility Returns After Recent Headlines - StocksToTrade
Sellas Life Sciences Expands SLS009 Program Into Europe With IMPACT-AML Agreement - StocksToTrade
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 5.5%Should You Sell? - MarketBeat
SELLAS partners with IMPACT-AML for European SLS009 trials By Investing.com - Investing.com Nigeria
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement - Yahoo Finance
How SELLAS’s IMPACT-AML Trial Expansion At SELLAS Life Sciences Group (SLS) Has Changed Its Investment Story - simplywall.st
SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout - Asianet Newsable
SELLAS partners with IMPACT-AML for European SLS009 trials - Investing.com
New leukemia drug combo to reach more European patients in joint trial - Stock Titan
Aug Fed Impact: Is CACC trading at a discountVolume Spike & Fast Moving Stock Trade Plans - baoquankhu1.vn
SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 REGAL Trial Progress - Quiver Quantitative
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Up 10.3%Here's What Happened - MarketBeat
Sellas Life Sciences Jumps in Volatile Session After Recent Selloff - StocksToTrade
Best Penny Stocks To Follow TodayJanuary 4th - MarketBeat
Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat
Sellas Life Sciences Rebounds After Volatile Selloff - timothysykes.com
Sellas Life Sciences Stock Slides as Trading Dynamics Overshadow Trial Timeline Update - StocksToTrade
Published on: 2026-01-10 22:25:31 - Улправда
SELLAS Stock Dips Amid Volatility After Warrant Exercise Update - StocksToTrade
SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? - Asianet Newsable
SLS Stock Slides Amid Volatility as Traders Focus on Dilution Concerns - timothysykes.com
SELLAS Life Sciences Falls For Fourth Straight SessionWhat's Driving The Sell Off? - Menafn
Published on: 2026-01-08 22:04:52 - Улправда
Is SELLAS Life Sciences Group Inc. stock a top pick in earnings seasonJuly 2025 Catalysts & Expert-Curated Trade Recommendations - Улправда
Published on: 2026-01-09 05:48:17 - Улправда
Why SELLAS Life Sciences Group Inc. stock could outperform in 2025July 2025 Breakouts & AI Powered Buy/Sell Recommendations - Улправда
Investment Review: Why global investors buy SELLAS Life Sciences Group Inc. (RXK3) stock2025 Valuation Update & Scalable Portfolio Growth Ideas - ulpravda.ru
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire
SELLAS Life Sciences Group stock soars as it nears final analysis in cancer study - MSN
Dip Buying: How interest rate cuts could boost SELLAS Life Sciences Group Inc. stockJuly 2025 Earnings & AI Optimized Trading Strategy Guides - ulpravda.ru
SELLAS Raises $26.5 Million Through Warrant Exercises - TipRanks
SLS Stock Breaches $5 Level After Over 3 Years: Retail Now Eyes Buyout For As Much As $25B - Asianet Newsable
Penny Stocks To Follow TodayJanuary 3rd - MarketBeat
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 8.4%Here's Why - MarketBeat
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
A Look At SELLAS Life Sciences Group (SLS) Valuation As REGAL Phase 3 Trial Nears Final Event Trigger - simplywall.st
SELLAS Life Sciences Group (SLS) Is Up 50.8% After REGAL Trial Nears Final OS TriggerHas The Bull Case Changed? - Yahoo Finance
Sellas Life Sciences Group Inc (SLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):